Acorda Therapeutics Earnings: Everything You Must Know Now

Acorda Therapeutics, Inc. (NASDAQ:ACOR) delivered a profit and beat Wall Street’s expectations, AND beat the revenue expectation. The revenue beat is a positive sign to shareholders seeking high growth out of the company. Shares are down 0%.

Acorda Therapeutics, Inc. Earnings Cheat Sheet

Results: Adjusted Earnings Per Share decreased 0% to $0.24 in the quarter versus EPS of $0.32 in the year-earlier quarter.

Revenue: Rose 12.2% to $81.5 million from the year-earlier quarter.

Actual vs. Wall St. Expectations: Acorda Therapeutics, Inc. reported adjusted EPS income of $0.24 per share. By that measure, the company beat the mean analyst estimate of $0.15. It beat the average revenue estimate of $78.9 million.

Quoting Management: “We are pleased with the performance of AMPYRA in 2012, and excited about the franchise’s potential to expand in future years. AMPYRA sales grew approximately 26% in 2012 over 2011, and we expect sales to continue to increase in 2013. In addition, results from our life cycle management programs in post-stroke deficits and cerebral palsy are projected to read out in the second quarter of 2013,” said Ron Cohen, M.D., Acorda Therapeutics’ President and CEO.

Key Stats (on next page)…

Revenue increased 5.24% from $77.44 million in the previous quarter. EPS decreased 0% from $0.24 in the previous quarter.

Looking Forward: Analysts have a more negative outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings has fallen from a profit of $0.17 to a profit $0.14. For the current year, the average estimate has moved up from a profit of $0.65 to a profit of $0.69 over the last ninety days.

Stocks with improving earnings metrics are worthy of your extra attention. In fact, “E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our CHEAT SHEET investing framework for this very reason. Don’t waste another minute – click here and get our CHEAT SHEET stock picks now.

(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at]